Chemistry:Sivelestat
From HandWiki
Short description: Chemical compound
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | IV |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C20H22N2O7S |
Molar mass | 434.46 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Sivelestat (INN, research name ONO 5046, marketed as Elaspol) is an inhibitor of human neutrophil elastase.[1]
It is used in the treatment of acute respiratory failure[2] and preliminary studies show it may also improve neuropathic pain.[3]
Synthesis
Sivelestat is synthesised as follows:[4]
References
- ↑ "ONO-5046, a novel inhibitor of human neutrophil elastase". Biochemical and Biophysical Research Communications 177 (2): 814–820. June 1991. doi:10.1016/0006-291X(91)91862-7. PMID 2049103.
- ↑ "[Acute respiratory failure due to pneumocystis pneumonia successfully treated with combined use of sivelestat sodium hydrate]" (in Japanese). Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society 46 (6): 461–465. June 2008. PMID 18592991.
- ↑ "Repurposing a leukocyte elastase inhibitor for neuropathic pain". Nature Medicine 21 (5): 429–430. May 2015. doi:10.1038/nm.3861. PMID 25951529.
- ↑ Imaki K, Arai Y, Okegawa T, "Derivatives of p-substituted phenyl ester of pivalic acid", US patent 5017610, issued 21 May 1991, assigned to Ono Pharmaceutical Co Ltd
![]() | Original source: https://en.wikipedia.org/wiki/Sivelestat.
Read more |